Expert Interview
Discussing Scholar Rock's Phase 2 results EMBRAZE trial results demonstrating statistically significant preservation of lean mass with Apitegromab during Tirzepatide-induced weight loss.
Ticker(s): SRRKInstitution: Yale School of Medicine
- Endocrinologist specializing in diabetes, obesity, and sleep disorders, with board certifications in internal medicine, endocrinology, and sleep medicine.
- Assistant Professor researching the interplay of obesity, diabetes, and sleep apnea, with over eight publications on glucose regulation and SGLT2 inhibitors.
- Directs obesity medicine and weight management programs, integrating novel pharmacotherapies for chronic disease management.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
